Not Yet RecruitingNot Applicable

Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation

1,000 participantsStarted 2022-10-01

Plain-language summary

The aims of this study are to 1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO). 2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO. 3. Evaluate the predictors for neoaortic valve regurgitation after ASO. 4. Explore the risk factors for neopulmonary artery stenosis after ASO.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: ·Participants with the diagnosis of TGA or TBA underwent ASO. Exclusion Criteria: * Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire procedure * Patients with various forms of TGA undergoing Rastelli procedure * Patients with various forms of TGA undergoing Nikaidoh procedure * Patients with various forms of TGA undergoing Fontan operation * Patients with various forms of TGA undergoing atrial repair (Mustard or Senning) operations * ASO is used as a corrective therapy for prior operations.

What they're measuring

All cause mortality

Timeframe: Ten years

Trial details

NCT IDNCT04980339

SponsorXie Mingxing

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-10-31

Contact for this trial

Li Zhang, PhD

18907131488 zli429@hust.edu.cn

View on ClinicalTrials.gov More Arterial Switch Operation trials